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Staphylococcus aureus is a major nosocomial pathogen
that causes a range of diseases, including endocarditis,
osteomyelitis, pneumonia, toxic-shock syndrome, food
poisoning, carbuncles, and boils. In the early 1950s,
acquisition and spread of beta-lactamase-producing plasmids
thwarted the effectiveness of penicillin for treating S. aureus
infections. In 1959, methicillin, a synthetic penicillin, was
introduced. However, by 1960, methicillin-resistant S. aureus
strains were identified, the direct result of S. aureus acquiring
the  mecA gene, which encodes for an altered penicillin-
binding protein gene (PBP2a) (1).
By the early 1960s, European hospitals were reporting
outbreaks of MRSA infections, and subsequently MRSA
clones spread to health-care institutions around the world (2).
In the United States, MRSA is responsible for approximately
25% of nosocomial infections, and reports of community-
acquired MRSA infections are increasing (3). The multidrug-
resistant phenotype of MRSA strains and their intrinsic beta-
lactam resistance make them difficult and costly to treat (4,5).
In some medical institutions in New York City, MRSA
accounts for approximately 29% of nosocomial infections and
50% of associated deaths (5). Controlling MRSA remains a
primary focus of most hospital infection control programs (6).
Bacterial strain typing, or subspeciation, has become an
important clinical tool to investigate suspected outbreaks and
to evaluate nosocomial transmission. Numerous typing
methods focus on discriminating MRSA isolates. We discuss
the limitations of current image-based genotyping methods
and the advantages of using DNA sequence analysis to control
MRSA infections in health-care settings.
Genotyping Aims
Bacterial strain typing distinguishes epidemiologically
related or clonal isolates from unrelated isolates. Epidemio-
logically related isolates are viewed as descendants from a
common precursor cell; thus, their genomic “fingerprints” will
be indistinguishable but recognizably different from
unrelated or random isolates from the same species (7).
Outbreak investigations of S. aureus and other nosocomial
pathogens are viewed as short-term events or cases of local
epidemiology, and in these settings most genotyping methods
are able to distinguish clonal spread from unrelated isolates.
Understanding genetic relatedness becomes more
challenging when the strain study population is larger,
separated further in time, and recovered from a larger
geographic area. The long-term or global epidemiologic
question is whether the strains causing disease in one
geographic area are related to those causing disease in other
regions. A combination of genotyping methods has been used
to study global S. aureus transmission (8,9).
In addition to tracking outbreaks, genotyping is used to
distinguish between contaminating and infecting isolates and
between separate episodes of infection and relapse of disease
(10). Genotyping is also able to link certain S. aureus clonal
types and disease syndromes, such as in cases of food
poisoning and toxic-shock syndrome. The present challenge is
to continue to build bacterial databases linking genetic
markers and clinical presentations so that important
correlates of disease can be identified.
Typing Staphylococcus aureus
Numerous techniques are available to differentiate S.
aureus, and specifically MRSA, isolates. Historically, isolates
were distinguished by phenotypic methods, including
antibiotic susceptibility testing and bacteriophage typing.
Both methods have limitations, as genetically unrelated
isolates commonly have the same antibiogram, and many S.
aureus isolates are nontypeable by phage typing (7).
With the advent of molecular biology, strain typing
focused on DNA-based methods. Initial techniques compared
restriction endonuclease patterns of chromosomal or plasmid
DNA. The second generation of genotyping methods included
Southern blot hybridization using gene-specific probes,
ribotyping, polymerase chain reaction (PCR)-based ap-
proaches, and pulsed-field gel electrophoresis (PFGE) (10,11).
These methods require subjective interpretation and
comparison of patterns and fingerprint images. The ability to
digitize and store images and to compare patterns by using
matching software programs has enhanced these methods.
However, they still remain difficult to standardize between
laboratories, and the image-based information is difficult to
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organize for rapid search and retrieval by computer. In addition,
image-based methods do not provide biological criteria to
evaluate the relatedness between different strains (12).
Binary typing is a more objective genotyping method that
compares the presence or absence of 12 different targets in the
S. aureus genome. The binary coding system for each probe
creates a numerical type amenable to relational databases
(13). However, binary typing fails to provide information on
genetic relatedness between strain types. This method is also
technically subjective, as it requires interpretation of a
positive hybridization signal from background.
DNA Sequence Analysis
DNA sequence analysis is an objective genotyping
method; the genetic code (A-T-C-G) is highly portable and
easily stored and analyzed in a relational database. Recent
advances in DNA sequencing technology, including rapid,
affordable, high-throughput systems, have made it possible
for sequencing to be considered as a viable typing method.
Sequencing the same DNA targets from disparate
isolates and then cataloging mutation patterns constitute an
approach termed comparative sequencing. Two different
strategies have been used to provide genotyping data:
multilocus sequence typing (MLST), which compares
sequence variation in numerous housekeeping gene targets,
and single-locus sequence typing, which compares sequence
variation of a single target.
MLST has been developed for Neisseria gonorrhoeae,
Streptococcus pneumoniae, and S. aureus, based on the classic
multilocus enzyme electrophoresis (MLEE) method used to
study the genetic variability of a species. Sequence analysis of
five to seven housekeeping genes provides a database from
which to infer relationships in somewhat distantly related
isolates that have had substantial time to diversify (14,15).
The MLST approach is too labor-intensive, time-
consuming, and costly to use in a clinical setting. More than
2,500 bp must be compared for each isolate. In addition, for
certain recent subpopulations, such as MRSA, genetic
variability in the housekeeping targets will likely be limited
and discrimination will be restricted. However, a single-locus
target, if discriminating, provides an inexpensive, rapid,
objective, and portable genotyping method to subspeciate
bacteria. Using a single target depends on finding a region for
sequencing that is sufficiently polymorphic to provide useful
strain resolution. Loci with short sequence repeat (SSR)
regions may have suitable variability for discriminating
outbreaks (16). Two S. aureus genes conserved within the
species, protein A (spa) and coagulase (coa), have variable
SSR regions constructed from closely related 24- and 81-bp
tandem repeat units, respectively. In both genes, the in-frame
SSR units are degenerative, variable in number, and variable
in the order in which repeat units are organized. The genetic
alterations in SSR regions include both point mutations and
intragenic recombination that arise by slipped-strand
mispairing during chromosomal replication and that result in
a high degree of polymorphism (17,18).
Frenay et al. (19) compared the SSR region in the protein
A gene in a collection of MRSA isolates studied by classical
bacteriophage typing and showed that spa-typing clustered
isolates previously grouped to phage type III-29. However,
van Belkum et al. questioned whether the repeat region was
too hypervariable and thus not a sound target for
epidemiologic studies (20).
Validation of spa-Typing
The spa-type database of the Public Health Research
Institute Tuberculosis Center includes >950 clinical S. aureus
isolates; most (~80%) are methicillin resistant. DNA
sequence analysis identified 37 unique, 24-bp SSR types; one
type was 1 codon longer. The number and organization of the
repeat types define the S. aureus spa type; to date, 186 spa
types have been identified and catalogued in a relational
database.
To further evaluate the clinical and epidemiologic
validity of the protein A repeat region as a genotyping tool, we
analyzed two historic collections previously characterized by
multiple genetic methods. The Centers for Disease Control
and Prevention’s (CDC) collection of 59 staphylococci included
58 S. aureus isolates, 37 of them methicillin resistant; 29
isolates had been previously grouped into four identifiable
clusters based on sound epidemiologic links. These isolates
have been repeatedly studied with an array of techniques
(e.g., phage typing, antibiograms, PFGE, ribotyping; Table 1).
In the CDC collection, 22 SSR regions and 13 different spa
types were identified. spa-typing correctly classified 27 of the
29 outbreak cultures and incorrectly grouped four isolates to
these clusters. Overall, spa-typing produced results better
than the mean score of 25 correct classifications and 5
misclassifications (18). These results support the findings of
Frenay et al. (19) that spa-typing has the stability to correctly
group epidemiologically related strains.
The second collection we analyzed consisted of 261 MRSA
isolates from 12 New York City hospitals historically
catalogued by Southern blot hybridization using mecA and
Tn554 and by PFGE. Together, these two methods identified
39 genotypes, which were further categorized into 96 PFGE
subtypes. Five major MRSA clonal types were identified, and
the predominant mecA:Tn554:PFGE genotype (I:A:A) was
found at each of the 12 hospitals. Of the 261 MRSA isolates,
107 were typed as I:A:A. Twenty-two similar PFGE patterns
were grouped to the “A” type (12). We named this genotype
pattern, which has been routinely identified as the
predominant MRSA clone in the United States, the “North
American” MRSA clone (unpub. data). spa-typing correctly
identified the five major MRSA clonal groups and also
Table 1. Comparison of typing methods used to discriminate
Staphylococcus aureus strains
Total no.      No.         No.
Method  of types classified misclassified
Phage typing 18 25 4
Antibiogram 21 26 6
Biotype 23 17 2
Plasmids 20 23 0
HindIII ribotyping 16 27 7
ClaI ribotyping   9 29 7
IS typing   9 16 3
RFLP typing 17 28 3
coa-PCR 7 28 8
PFGE 25 28 7
FIGEa 25 27 3
Immunoblotting 23 28 6
MLEE 21 26 4
Range   7-25 16-28 0-8
Average 18 25 5
spa-typing 16 27 4
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categorized 98 of the 107 I:A:A MRSA isolates as spa type 2;
the remaining 9 isolates were distributed in five different spa
types, which were grouped by repeat composition and repeat
organization (Table 2).
To test the genetic validity of spa-typing, we sequenced
the SSR region of the coagulase gene. The slower “clock-speed”
of the larger coagulase repeat region provided an independent
genetic target to compare evolutionary relatedness with the
results provided by spa-typing. Sequence analysis revealed a
common coa type among seven of the nine spa types (Table 2),
providing additional, independent evidence of genetic
relatedness of the I:A:A MRSA isolates.
The PFGE fingerprint patterns in the North American
MRSA clonal types listed in Table 2 were determined
(Figure). The isolates with spa types 14, 25, and 28 (lanes 5, 9,
and 6, respectively) were grouped to the North American
clonal type on the basis of spa composition and organization
and  coa type. However, these isolates were initially
distinguished by different mecA:Tn554 genotypes and more
diverse PFGE patterns.
Conclusions
The finding that spa-typing could genotype the S. aureus
isolates from two different collections in congruence with
established procedures disproves the belief that this repeat
region is too unstable for epidemiologic studies. While spa-
typing does not have the resolving power of PFGE subtyping,
it is fast, easy to use and interpret, and compatible for
building relational databases. Most importantly, DNA
sequence analysis of the protein A repeat region provides an
unambiguous, portable dataset that simplifies information
sharing between laboratories and facilitates creating a large-
scale database for studying global and local epidemiology.
The MLST database of S. aureus should establish a sound
genetic framework to describe the species (14). These data are
portable and can be easily linked to a spa and coa database, a
process that takes advantage of the objective nature of
sequence information. The spa-short repeat region and its
variation in both composition and organization have
established a library of distinguishable patterns that allows
isolates to be easily and accurately genotyped. These
groupings are supported by other image-based genotyping
methods and sequencing secondary targets such as the
coagulase short sequence repeats (17).
Although still limited in number, isolates that have been
genotyped on the basis of mecA:Tn554:PFGE fingerprint
Table 2. Genotype of the “North American” MRSA clone
Isolates
(no. = 107) mecA Tn554 PFGE spa type spa-type repeats coa-type repeats
98   I  A A spa type 2 T-J-M-B-M-D-M-G-M-K A-B-C-D-E-F
  2   I  A A spa type 24 T-J-M-E-M-D-M-G-M-K
  1   I  A A spa type 23 T-J-M-B-M-D-M-G-K A-B-C-D-E-F
  2   I  A A spa type 29 T-J-M-B-M-D-M-G-G-M-K A-B-C-D-E-F
  1   I  A A spa type 60 T-J-M-A-M-G-M-K
  3   I  A A spa type 26 T-J-M-B-M-G-M-K A-B-C-D-E-F
New isolates mecA PFGE
  1  II NH A' spa type 14 T-J-M-B-M-D-M-G-M-K-K A-B-C-D-E-F
  1  II NH A' spa type 25 T-J-M-D-M-G-M-K A-B-C-D-E-F
  1 III NH A' spa type 28 T-K-J-M-B-M-D-M-G-M-K-K A-B-C-D-E-F
Figure. SmaI-pulsed-field gel electrophoresis of nine Staphylococcus
aureus strains representative of the most prevalent MRSA clonal
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patterns and spa- and coa-typing provide a rich database to
study the recent spread of S. aureus and MRSA clones. These
data provide sound evidence that SmaI-PFGE patterns
change at a faster clock-speed than do the protein A SSRs and
that the coagulase repeats change at a slower clock-speed
than the shorter protein A repeats.
In short, sequence typing permits the widespread use of a
proactive approach to investigate suspected outbreaks of
MRSA.
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